Menu Search
Equities

Krynica Vitamin SA

KVT:WSE

Krynica Vitamin SA

Actions
Consumer Staples Beverages
  • Price (PLN)9.62
  • Today's Change-0.10 / -1.03%
  • Shares traded317.00
  • 1 Year change-29.78%
  • Beta--
Data delayed at least 15 minutes, as of Nov 21 2024.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in PLNIncome statement in PLNView more

Year on year Krynica Vitamin SA's revenues fell -4.75% from 377.16m to 359.23m. This along with an increase in the cost of goods sold expense has contributed to a reduction in net income from a gain of 13.08m to a loss of 6.68m.
Gross margin15.37%
Net profit margin-0.91%
Operating margin0.13%
Return on assets-1.50%
Return on equity-3.99%
Return on investment-3.03%
More ▼

Cash flow in PLNView more

In 2023, Krynica Vitamin SA increased its cash reserves by 221.04%, or 1.70m. The company earned 21.54m from its operations for a Cash Flow Margin of 6.00%. In addition the company used 8.92m on investing activities and also paid 10.91m in financing cash flows.
Cash flow per share0.8736
Price/Cash flow per share11.01
Book value per share7.08
Tangible book value per share6.95
More ▼

Balance sheet in PLNView more

Krynica Vitamin SA has a Debt to Total Capital ratio of 34.74%, a higher figure than the previous year's 16.45%.
Current ratio0.8634
Quick ratio0.5096
Total debt/total equity0.5324
Total debt/total capital0.3474
More ▼

Growth rates in PLN

Year on year, growth in earnings per share excluding extraordinary items dropped -151.08%.
EPS growth(5 years)--
EPS (TTM) vs
TTM 1 year ago		-138.85
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.